Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05053412Completed

HELIO Liver Test Performance Study in China (HEPATIC)

Role: lead

NCT05181826Unknown

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Role: lead

NCT05199259Recruiting

Multi-analyte Blood Test Clinical Trial

Role: lead

NCT03694600Unknown

Clinical Trial Multi-analyte Blood Test

Role: lead

NCT05059665Completed

Performance Evaluation (Sensitivity/Specificity) of HelioLiver Test for Detection of HCC

Role: lead

All 5 trials loaded